<p>A, The graph shows the changes of mean proliferating cell density of the control and treated tumors post treatment. There was significant difference in proliferating cell density between control and treatment groups on days 2, 4 and 6 (* = <i>P</i><0.001). B, Representative KI67-stained sections of the control (C) and treated (T) tumors on days 0, 2, 4 and 6. Brown areas reflect positive staining of proliferating tumor cell. Scale bars: 50 µm.</p
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
All data are represented as percent total live cells, which include tumor cells as well as immune in...
<p>A, The graph shows the changes of mean tumor cell density of the control and treated tumors post ...
<p>A, The graph shows the changes of mean MVD in the control and treated tumors post treatment. Ther...
<p>A, The graph showed the changes of tumor perfusion post treatment. There was significant differen...
<p>The graphs in (a) compare the mean total cell density (left) and the mean MIB-1 positive cell den...
(A) Time related changes in the cell density obtained by the number of nuclei in an area of 10000 μm...
<p>Tumor control (Ki67, A), low-dose FALHE treatment (Ki67, B), high-dose FALHE treatment (Ki67, C),...
<p>(A) Heatmap shows diverse expression levels (log fold change of FPKM values) of immune evasion ge...
<p>(A) PCNA staining and the PI of tumor tissues in each group, 400 ×magnification, scale bar: 50 μm...
<p>The graphs show apoptotic cell density (a), cleaved caspase-3 density(b), and proliferating(Ki-67...
<p>Tumor cell apoptosis (TUNEL, A and B), tumor microvascular density (CD31, C and D), and tumor cel...
<p>(<b>A</b>) Representative images of CD31 positive microvessels and Ki-67 positive cells in tumor ...
<p>(<b>A</b>, top panel) haematoxylin and eosin staining showing leucocyte packed necrosis in U87MG ...
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
All data are represented as percent total live cells, which include tumor cells as well as immune in...
<p>A, The graph shows the changes of mean tumor cell density of the control and treated tumors post ...
<p>A, The graph shows the changes of mean MVD in the control and treated tumors post treatment. Ther...
<p>A, The graph showed the changes of tumor perfusion post treatment. There was significant differen...
<p>The graphs in (a) compare the mean total cell density (left) and the mean MIB-1 positive cell den...
(A) Time related changes in the cell density obtained by the number of nuclei in an area of 10000 μm...
<p>Tumor control (Ki67, A), low-dose FALHE treatment (Ki67, B), high-dose FALHE treatment (Ki67, C),...
<p>(A) Heatmap shows diverse expression levels (log fold change of FPKM values) of immune evasion ge...
<p>(A) PCNA staining and the PI of tumor tissues in each group, 400 ×magnification, scale bar: 50 μm...
<p>The graphs show apoptotic cell density (a), cleaved caspase-3 density(b), and proliferating(Ki-67...
<p>Tumor cell apoptosis (TUNEL, A and B), tumor microvascular density (CD31, C and D), and tumor cel...
<p>(<b>A</b>) Representative images of CD31 positive microvessels and Ki-67 positive cells in tumor ...
<p>(<b>A</b>, top panel) haematoxylin and eosin staining showing leucocyte packed necrosis in U87MG ...
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
All data are represented as percent total live cells, which include tumor cells as well as immune in...